Results 21 to 30 of about 10,362,887 (235)

Pharmacological treatment for Buerger's disease. [PDF]

open access: yesCochrane Database Syst Rev, 2020
BACKGROUND Buerger's disease (thromboangiitis obliterans) is a non-atherosclerotic, segmental inflammatory pathology that most commonly affects the small and medium sized arteries, veins, and nerves in the upper and lower extremities.
Cacione DG   +3 more
europepmc   +2 more sources

Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease). [PDF]

open access: yesCochrane Database Syst Rev, 2018
BACKGROUND Thromboangiitis obliterans, also known as Buerger's disease, is a non-atherosclerotic, segmental inflammatory pathology that most commonly affects the small- and medium-sized arteries, veins, and nerves in the upper and lower extremities.
Cacione DG   +2 more
europepmc   +2 more sources

Ischemic Colitis in Buerger's Disease: Case Presentation and Review. [PDF]

open access: yesCureus, 2020
Buerger’s disease is a type of vasculitis that predominantly affects small to medium arteries and the veins of the upper and lower extremities. Intestinal vessels are rarely involved.
Naqvi HA, Bilal M, Yousuf S.
europepmc   +2 more sources

Retinal Artery Occlusion Secondary to Buerger’s Disease (Thromboangiitis Obliterans) [PDF]

open access: yesCase Reports in Ophthalmological Medicine, 2017
Purpose. To report a case report of one patient suffering from retinal artery occlusion secondary to Buerger’s disease, in order to raise awareness to this etiology in the differential diagnosis of retinal artery occlusion. Methods.
Erdem Eris   +5 more
doaj   +2 more sources

Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan [PDF]

open access: yesBMC Cardiovascular Disorders, 2012
Background This study assessed the effectiveness and safety of bosentan when administered to thromboangiitis obliterans (Buerger's disease) patients.
De Haro Joaquin   +4 more
doaj   +3 more sources

Critical Limb Ischemia Due to Suspected Buerger's Disease in an Adolescent Patient: A Case Report. [PDF]

open access: yesCureus
Buerger’s disease is a segmental and inflammatory syndrome affecting relatively young individuals primarily and occurs with occlusion of small to medium-sized vessels in their extremities. The typical age for symptoms to appear is between 35 and 50 years
Silvestri O   +5 more
europepmc   +3 more sources

Detection of Rickettsia Endosymbiont Bemisia Tabaci in the Amputated Limbs of Three Buerger's Disease Patients. [PDF]

open access: yesInt Med Case Rep J, 2020
Until recently, the aetiology of Buerger’s disease (BD) has been unknown. Although there is a close relationship between BD and smoking, it cannot explain the low prevalence of BD among smokers or the disease’s geographical distribution.
Fazeli B   +3 more
europepmc   +2 more sources

Limb salvage in Buerger's disease by distraction histogenesis: A prospective study with literature review. [PDF]

open access: yesJ Clin Orthop Trauma, 2019
Buerger's disease or Thromboangiitisobliterans (TAO) affects small and medium sized blood vessels and is a disease of unknown etiology. Segmental inflammation of blood vessels is seen which then leads to interruption of the distal blood supply.1 It is a ...
Chouhan A   +5 more
europepmc   +2 more sources

Rare clinical presentations and advances in the treatment of Buerger's disease - narrative review [PDF]

open access: yesQuality in Sport
Introduction Buerger's disease (BD) is an inflammatory disease with an etiology that is still not fully understood. It involves venous and arterial vessels, of small and medium caliber, of the lower and upper extremities (Cacione et al., 2020).
Damian Chruścicki   +7 more
doaj   +3 more sources

Understanding Buerger's Disease: Symptoms, Diagnosis and Management Strategies [PDF]

open access: yesQuality in Sport
Buerger's disease, also known as thromboangiitis obliterans (TAO), is a rare but serious condition that primarily affects the blood vessels in the limbs.
Adrianna Muciek   +7 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy